Return On Equity of Sage Therapeutics, Inc. from 31 Mar 2015 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sage Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2015 to 30 Jun 2025.
  • Sage Therapeutics, Inc. Return On Equity for the quarter ending 30 Jun 2025 was -67%, a 11% decline year-over-year.
  • Sage Therapeutics, Inc. annual Return On Equity for 2024 was -68%, a 18% decline from 2023.
  • Sage Therapeutics, Inc. annual Return On Equity for 2023 was -58%, a 57% decline from 2022.
  • Sage Therapeutics, Inc. annual Return On Equity for 2022 was -37%, a 52% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Sage Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -67% -7% -11% 01 Apr 2025 30 Jun 2025
Q1 2025 -69% -8% -13% 01 Jan 2025 31 Mar 2025
Q4 2024 -68% -10% -18% 01 Oct 2024 31 Dec 2024
Q3 2024 -50% +12% +20% 01 Jul 2024 30 Sep 2024
Q2 2024 -60% -11% -21% 01 Apr 2024 30 Jun 2024
Q1 2024 -61% -19% -44% 01 Jan 2024 31 Mar 2024
Q4 2023 -58% -21% -57% 01 Oct 2023 31 Dec 2023
Q3 2023 -63% -30% -91% 01 Jul 2023 30 Sep 2023
Q2 2023 -50% -20% -66% 01 Apr 2023 30 Jun 2023
Q1 2023 -42% -15% -55% 01 Jan 2023 31 Mar 2023
Q4 2022 -37% -13% -52% 01 Oct 2022 31 Dec 2022
Q3 2022 -33% -65% -200% 01 Jul 2022 30 Sep 2022
Q2 2022 -30% -70% -175% 01 Apr 2022 30 Jun 2022
Q1 2022 -27% -74% -158% 01 Jan 2022 31 Mar 2022
Q4 2021 -24% -81% -144% 01 Oct 2021 31 Dec 2021
Q3 2021 33% +100% 01 Jul 2021 30 Sep 2021
Q2 2021 40% +108% 01 Apr 2021 30 Jun 2021
Q1 2021 47% +110% 01 Jan 2021 31 Mar 2021
Q4 2020 56% +116% 01 Oct 2020 31 Dec 2020
Q3 2020 -67% -7% -12% 01 Jul 2020 30 Sep 2020
Q2 2020 -68% -12% -21% 01 Apr 2020 30 Jun 2020
Q1 2020 -63% -20% -45% 01 Jan 2020 31 Mar 2020
Q4 2019 -60% -22% -60% 01 Oct 2019 31 Dec 2019
Q3 2019 -60% -28% -90% 01 Jul 2019 30 Sep 2019
Q2 2019 -56% -23% -68% 01 Apr 2019 30 Jun 2019
Q1 2019 -43% +14% +25% 01 Jan 2019 31 Mar 2019
Q4 2018 -37% +49% +57% 01 Oct 2018 31 Dec 2018
Q3 2018 -32% +58% +65% 01 Jul 2018 30 Sep 2018
Q2 2018 -33% +31% +49% 01 Apr 2018 30 Jun 2018
Q1 2018 -58% -3% -5.8% 01 Jan 2018 31 Mar 2018
Q4 2017 -86% -38% -80% 01 Oct 2017 31 Dec 2017
Q3 2017 -89% -43% -92% 01 Jul 2017 30 Sep 2017
Q2 2017 -65% -13% -26% 01 Apr 2017 30 Jun 2017
Q1 2017 -55% -5% -11% 01 Jan 2017 31 Mar 2017
Q4 2016 -48% +6% +12% 01 Oct 2016 31 Dec 2016
Q3 2016 -47% +2% +4.4% 01 Jul 2016 30 Sep 2016
Q2 2016 -51% -7% -17% 01 Apr 2016 30 Jun 2016
Q1 2016 -49% +7% +13% 01 Jan 2016 31 Mar 2016
Q4 2015 -54% 01 Oct 2015 31 Dec 2015
Q3 2015 -49% 01 Jul 2015 30 Sep 2015
Q2 2015 -44% 01 Apr 2015 30 Jun 2015
Q1 2015 -57% 01 Jan 2015 31 Mar 2015

Sage Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -68% -10% -18% 01 Jan 2024 31 Dec 2024
2023 -58% -21% -57% 01 Jan 2023 31 Dec 2023
2022 -37% -13% -52% 01 Jan 2022 31 Dec 2022
2021 -24% -81% -144% 01 Jan 2021 31 Dec 2021
2020 56% +116% 01 Jan 2020 31 Dec 2020
2019 -60% -22% -60% 01 Jan 2019 31 Dec 2019
2018 -37% +49% +57% 01 Jan 2018 31 Dec 2018
2017 -86% -38% -80% 01 Jan 2017 31 Dec 2017
2016 -48% +6% +12% 01 Jan 2016 31 Dec 2016
2015 -54% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.